Literature DB >> 11415459

Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants.

H Watanabe1, U Kragh-Hansen, S Tanase, K Nakajou, M Mitarai, Y Iwao, T Maruyama, M Otagiri.   

Abstract

Correctly folded recombinant wild-type human serum albumin and the single-residue mutants K199A, W214A, R218H and H242Q were produced with the use of a yeast expression system. The changes in R218H resulted in a pronounced decrease in intrinsic fluorescence. Thermodynamic parameters for thermal denaturation of the present mutants and of five additional mutants have been determined, showing small increases in stability for two mutants (R218H and H242Q) and a larger decrease in stability for one (W214A). In the last of these, denaturation was a heterogeneous process starting at physiological temperature. The high-affinity binding constant for warfarin at pH 7.4 was determined by fluorescence spectroscopy: there was a significant increase in affinity for binding of warfarin to H242Q and K199A and a smaller decrease in affinity for W214A and R218H. The findings show that Trp-214 is not as essential for the high-affinity binding of warfarin as has previously been thought.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11415459      PMCID: PMC1221951          DOI: 10.1042/0264-6021:3570269

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Atomic mutations at the single tryptophan residue of human recombinant annexin V: effects on structure, stability, and activity.

Authors:  C Minks; R Huber; L Moroder; N Budisa
Journal:  Biochemistry       Date:  1999-08-17       Impact factor: 3.162

2.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

3.  The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites.

Authors:  K J Fehske; W E Müller; U Wollert; L M Velden
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

4.  The absorption of warfarin from the rat small intestine in situ.

Authors:  R J Julkunen
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

5.  Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.

Authors:  K J Fehske; U Schläfer; U Wollert; W E Müller
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

Review 6.  Molecular aspects of ligand binding to serum albumin.

Authors:  U Kragh-Hansen
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

7.  Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.

Authors:  V Maes; Y Engelborghs; J Hoebeke; Y Maras; A Vercruysse
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

8.  Removal of fatty acids from serum albumin by charcoal treatment.

Authors:  R F Chen
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

9.  Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics.

Authors:  C E Petersen; C E Ha; K Harohalli; D S Park; N V Bhagavan
Journal:  Chem Biol Interact       Date:  2000-02-01       Impact factor: 5.192

Review 10.  Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine.

Authors:  S Pannain; M Feldman; U Eiholzer; R E Weiss; N H Scherberg; S Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

View more
  11 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  Bioactivity of albumins bound to silver nanoparticles.

Authors:  Jessy Mariam; S Sivakami; D C Kothari; P M Dongre
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

Review 3.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  A chloroplast transgenic approach to hyper-express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation.

Authors:  Alicia Fernández-San Millán; Angel Mingo-Castel; Michael Miller; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2003-03       Impact factor: 9.803

5.  Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo.

Authors:  Makoto Anraku; Ulrich Kragh-Hansen; Keiichi Kawai; Toru Maruyama; Yasuomi Yamasaki; Yoshinobu Takakura; Masaki Otagiri
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

6.  The investigation of the binding of 6-mercaptopurine to site I on human serum albumin.

Authors:  Jolanta Sochacka; Wojciech Baran
Journal:  Protein J       Date:  2012-12       Impact factor: 2.371

7.  Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.

Authors:  Nathan E Basken; Carla J Mathias; Mark A Green
Journal:  J Pharm Sci       Date:  2009-06       Impact factor: 3.534

8.  A Comparative Interaction between Copper Ions with Alzheimer's β Amyloid Peptide and Human Serum Albumin.

Authors:  G Rezaei Behbehani; L Barzegar; M Mohebbian; A A Saboury
Journal:  Bioinorg Chem Appl       Date:  2012-07-09       Impact factor: 7.778

9.  Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin.

Authors:  Hiroki Sato; Victor Tuan Giam Chuang; Keishi Yamasaki; Noriyuki Yamaotsu; Hiroshi Watanabe; Kohei Nagumo; Makoto Anraku; Daisuke Kadowaki; Yu Ishima; Shuichi Hirono; Masaki Otagiri; Toru Maruyama
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Binding of Sulpiride to Seric Albumins.

Authors:  Viviane Muniz da Silva Fragoso; Carla Patrícia de Morais Coura; Luanda Yanaan Hoppe; Marília Amável Gomes Soares; Dilson Silva; Celia Martins Cortez
Journal:  Int J Mol Sci       Date:  2016-01-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.